Biotech

All Articles

Bicara, Zenas look for IPOs to push late-phase possessions toward market

.Bicara Rehabs and also Zenas Biopharma have actually supplied new inspiration to the IPO market alo...

Genentech to shut cancer immunology research study department

.Genentech is going to close its cancer immunology analysis division, and unit mind and well-known c...

Kezar falls sound cyst but to verify its truly worth in period 1 trial

.Kezar Life Sciences is actually falling its own unpromising period 1 strong growth medication as th...

Acelyrin loses izokibep, dismisses 3rd of workers

.Even with izokibep maintaining its newly found winning streak in the medical clinic, Acelyrin is no...

Rivus' phase 2 obesity-related heart failure test hits endpoint

.Rivus Pharmaceuticals has plumped up the prospects of its own fat-busting, muscle-sparing medicatio...

Ovid standstills preclinical job, IV program after soticlestat fall short

.Ovid Therapy presently disclosed last month that it was actually trimming its own head count as the...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston Seaport

.Eli Lilly has opened a $700 million R&ampD facility in the Boston ma Port, boosting its RNA and als...

Boundless Biography produces 'modest' cutbacks five months after $100M IPO

.Only 5 months after securing a $one hundred million IPO, Limitless Bio is actually actually laying ...

Halda's $126M will progress 'secure as well as get rid of' cyst medications

.The first phases of oncology R&ampD aren't except interesting brand new modalities, and also Halda ...

Lykos 'regrets' certainly not revealing research study offenses along with publisher

.Psychopharmacology has actually taken three articles about midstage clinical test records assessing...